glp-1 serena Williams Super Bowl Commercial Pitches From Ro Serena Williams Opens Up About
Description
Wegovy comes in 5 strengths .25, .5, 1, 1.7 and 2.4 mg
2.3 Outcomes The primary outcomes of the study were change in TIR from the first 5 days compared to the second 5 days of CGM wear, and change in HbA1c level from baseline to follow up at 3-6 months
It is important to note that higher-dose semaglutide (2.4 mg, marketed as Wegovy) is licensed specifically for weight management in obesity and has separate eligibility criteria and dosing from the diabetes indication
Meanwhile, 67% of GLP-1 medication users have diabetes
